» Authors » Robert Harrington

Robert Harrington

Explore the profile of Robert Harrington including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 2164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Rodriguez F, Coquet J, Harrington R, Hernandez-Boussard T
Public Health Rep . 2021 Jun; 136(5):543-547. PMID: 34161176
Racial/ethnic minority groups are disproportionately affected by the COVID-19 pandemic. We examined ethnic differences in SARS-CoV-2 testing patterns and positivity rates in a large health care system in Northern California....
12.
Harrington R, Al Nokhatha S, Conway R
Biologics . 2021 Jan; 15:17-29. PMID: 33442231
Glucocorticoids have been the mainstay of treatment in giant cell arteritis (GCA) for the past 70 years. Conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) have largely failed to show significant clinical...
13.
Hu S, Cavanagh B, Harrington R, Ahmad M, Kearns G, Meaney S, et al.
Int J Mol Sci . 2020 Dec; 21(23). PMID: 33287382
Microparticles are sub-micron, membrane-bound particles released from virtually all cells and which are present in the circulation. In several autoimmune disorders their amount and composition in the circulation is altered....
14.
Erly S, Roberts D, Kerani R, Kim H, Harrington R, Dhanireddy S, et al.
J Immigr Minor Health . 2020 Nov; 23(6):1136-1144. PMID: 33206277
To examine the relationship between African birth and HIV outcomes and comorbidities among individuals accessing care at the University of Washington. Patients who received a diagnosis of HIV at the...
15.
Ward A, Sarraju A, Chung S, Li J, Harrington R, Heidenreich P, et al.
NPJ Digit Med . 2020 Oct; 3:125. PMID: 33043149
The pooled cohort equations (PCE) predict atherosclerotic cardiovascular disease (ASCVD) risk in patients with characteristics within prespecified ranges and has uncertain performance among Asians or Hispanics. It is unknown if...
16.
Harrington R, Al Nokhatha S, Conway R
J Inflamm Res . 2020 Sep; 13:519-531. PMID: 32982367
Janus kinase (JAK) Inhibitors are the latest drug class of disease-modifying medication to emerge for the treatment of rheumatoid arthritis (RA). They are a small molecule-targeted treatment and are the...
17.
Al Nokhatha S, Harrington R, Conway R
Joint Bone Spine . 2020 Jul; 87(6):535-537. PMID: 32622034
No abstract available.
18.
Gibbons E, Huang G, Aldea G, Koomalsingh K, Klein J, Dhanireddy S, et al.
Crit Pathw Cardiol . 2020 Apr; 19(4):187-194. PMID: 32282401
Clinical pathways can be useful when disparate clinical-pathologic groups converge on a common diagnostic and therapeutic trajectory. The progressive increase in the incidence of endocarditis in the US has included...
19.
Motamedi M, Shahbaz S, Fu L, Dunsmore G, Xu L, Harrington R, et al.
Immunohorizons . 2019 Nov; 3(11):531-546. PMID: 31732662
NK cell functions are tightly regulated by the balance between the inhibitory and stimulatory surface receptors. We investigated the surface expression of galectin-9 (Gal-9) and its function in NK cells...
20.
Abnousi F, Kang G, Giacomini J, Yeung A, Zarafshar S, Vesom N, et al.
NPJ Digit Med . 2019 Aug; 2:80. PMID: 31453375
Current remote monitoring devices for heart failure have been shown to reduce hospitalizations but are invasive and costly; accurate non-invasive options remain limited. The EuleriAn Video Magnification ApPLications In Heart...